Evidence map›Paper›PMID 35120040›Full record

Trial reportCritical care medicine2022

Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial.

Anne M Drewry, Nicholas M Mohr, Enyo A Ablordeppey, Catherine M Dalton, Rebecca J Doctor, Brian M Fuller, Marin H Kollef, Richard S Hotchkiss

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. The poikilothermic hypothesis of sepsis.Critical care (London, England) · 2026
    Review
  3. Article
  4. Article
  5. Sepsis in the absence of fever: Determining the criteria for and feasibility of future therapeutic temperature management trials.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2025
    Article
  6. Article
  7. Fever in Sepsis Revisited: Is a Little Heat What We Need?Open forum infectious diseases · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Temperature control in sepsis.Frontiers in medicine · 2023
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anne M DrewryDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO.
Nicholas M MohrDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO.
Enyo A AblordeppeyDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO.
Catherine M DaltonDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO.
Rebecca J DoctorDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO.
Brian M FullerDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO.
Marin H KollefDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Richard S HotchkissDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO.
Washington University in St. Louis · US

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
Enhancing Innate and Adaptive Immunity to Improve Sepsis SurvivalR35GM126928 · NIGMS · WASHINGTON UNIVERSITY · PI Richard Samuel Hotchkiss · 2018 to 2026
$4.7M
Washington University K12 Program in T4 Implementation ResearchK12HL137942 · NHLBI · WASHINGTON UNIVERSITY · PI DAVILA-ROMAN, VICTOR G. · 2017 to 2021
$3.1M
Evaluating the Role of Telemedicine in Improving Rural Emergency Department Sepsis CareK08HS025753 · AHRQ · UNIVERSITY OF IOWA · PI MOHR, NICHOLAS M. · 2019 to 2023
$717k
Immunological Phenotyping of Febrile and Afebrile Critically Ill Septic PatientsK23GM129660 · NIGMS · WASHINGTON UNIVERSITY · PI DREWRY, ANNE MEREDITH · 2018 to 2020
$535k
AHRQ HHS K08 HS025753NCATS NIH HHS KL2 TR000450NCATS NIH HHS UL1 TR000448NHLBI NIH HHS K12 HL137942NIGMS NIH HHS K23 GM129660NIGMS NIH HHS L30 GM134513NIGMS NIH HHS R35 GM126928
6 · The paper itself

Abstract

objectivesTo test the hypothesis that forced-air warming of critically ill afebrile sepsis patients improves immune function compared to standard temperature management.

designSingle-center, prospective, open-label, randomized controlled trial.

settingOne thousand two hundred-bed academic medical center. PATIENTS: Eligible patients were mechanically ventilated septic adults with: 1) a diagnosis of sepsis within 48 hours of enrollment; 2) anticipated need for mechanical ventilation of greater than 48 hours; and 3) a maximum temperature less than 38.3°C within the 24 hours prior to enrollment. Primary exclusion criteria included: immunologic diseases, immune-suppressing medications, and any existing condition sensitive to therapeutic hyperthermia (e.g., brain injury). The primary outcome was monocyte human leukocyte antigen (HLA)-DR expression, with secondary outcomes of CD3/CD28-induced interferon gamma (IFN-γ) production, mortality, and 28-day hospital-free days.

interventionsExternal warming using a forced-air warming blanket for 48 hours, with a goal temperature 1.5°C above the lowest temperature documented in the previous 24 hours. MEASUREMENTS AND MAIN

resultsWe enrolled 56 participants in the study. No differences were observed between the groups in HLA-DR expression (692 vs 2,002; p = 0.396) or IFN-γ production (31 vs 69; p = 0.678). Participants allocated to external warming had lower 28-day mortality (18% vs 43%; absolute risk reduction, 25%; 95% CI, 2-48%) and more 28-day hospital-free days (difference, 2.6 d; 95% CI, 0-11.6).

conclusionsParticipants randomized to external forced-air warming did not have a difference in HLA-DR expression or IFN-γ production. In this pilot study, however, 28-day mortality was lower in the intervention group. Future research should seek to better elucidate the impact of temperature modulation on immune and nonimmune organ failure pathways in sepsis.

Indexed as

COVID-19Hyperthermia, InducedSepsisAdultCritical IllnessHLA-DR AntigensHumansPilot ProjectsProspective StudiesSARS-CoV-2HLA-DR Antigens

Identifiers

PMID35120040
PMCPMC9133030
OpenAlexW4210484842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.